STOCK TITAN

Butterfly Network Inc SEC Filings

BFLY NYSE

Welcome to our dedicated page for Butterfly Network SEC filings (Ticker: BFLY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Butterfly Network, Inc. (NYSE: BFLY) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. These filings give investors and analysts detailed insight into Butterfly’s financial reporting, corporate actions and material events related to its handheld ultrasound devices, Ultrasound-on-Chip™ semiconductor technology and digital health software platforms.

Recent Form 8-K filings for BFLY cover several key topics. Some 8-Ks furnish press releases announcing quarterly financial results and preliminary revenue expectations, along with business updates on AI initiatives, chip development milestones and enterprise software such as Compass™ and Compass AI™. Other 8-Ks describe executive leadership changes, including the appointment of a new Chief Financial Officer and related compensation and severance arrangements for finance executives.

Butterfly’s filings also document material agreements. For example, an 8-K dated November 17, 2025 describes a Co-Development and Licensing Agreement with Midjourney, Inc., under which Butterfly grants an exclusive, non-transferable license within a specified field of use to certain Ultrasound-on-Chip technology, software and backend technology, in exchange for specified fees, milestone payments, revenue sharing and chip-related payments. This type of filing helps readers understand how Butterfly’s semiconductor platform is being licensed to partners.

Another notable 8-K, dated January 13, 2026, reports that the New York Stock Exchange has determined to commence proceedings to delist Butterfly’s public warrants (ticker BFLY WS) and suspend trading in those warrants due to "abnormally low selling price" levels under NYSE rules. The filing states that this action does not affect trading in Butterfly’s Class A common stock, which continues on the NYSE under the symbol BFLY.

On Stock Titan, these SEC documents are supplemented with AI-powered summaries that highlight the main points of each filing, helping readers quickly understand topics such as results of operations, material contracts, leadership changes and listing status. Users can review Forms 8-K for event-driven updates, and refer to annual and quarterly reports (Forms 10-K and 10-Q) for broader financial and operational details as they become available through the SEC’s EDGAR system.

Rhea-AI Summary

Butterfly Network, Inc. received an updated ownership report showing that Fosun Industrial Co., Limited and its parent Shanghai Fosun Pharmaceutical (Group) Co., Ltd. together beneficially own 10,716,630 shares of Butterfly’s Class A common stock, representing 4.7% of the class as of December 31, 2025.

The filing states all 10,716,630 shares are held by Fosun Industrial, with both Fosun entities sharing voting and dispositive power. The 4.7% figure is calculated against 226,175,175 Class A shares outstanding as of October 21, 2025, and the investors certify the stake is held on a passive basis, not to influence control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Butterfly Network, Inc. is having its redeemable warrants removed from listing and registration on the New York Stock Exchange. These securities are redeemable warrants, with each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

The Vanguard Group filed a Schedule 13G reporting a passive ownership stake in Butterfly Network Inc. common stock. Vanguard reports beneficial ownership of 11,315,969 shares, representing 5% of the class as of the event date of 12/31/2025.

Vanguard has shared voting power over 1,457,633 shares and shared dispositive power over 11,315,969 shares, with no sole voting or dispositive power. The filing notes an internal realignment effective January 12, 2026, after which certain Vanguard subsidiaries are expected to report beneficial ownership separately. Vanguard certifies the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Butterfly Network.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Butterfly Network, Inc. reports that the New York Stock Exchange will delist, and has immediately suspended trading in, its public warrants (ticker BFLY WS) because of “abnormally low selling price” levels under Section 802.01D of the NYSE Listed Company Manual as of January 13, 2026. Each warrant was issued in the February 16, 2021 business combination with Longview Acquisition Corp. and is exercisable for one share of Class A common stock at an exercise price of $11.50 per share until its expiration on February 12, 2026. The company states it does not believe the warrant delisting is related to its performance, and confirms that trading in its Class A common stock, which continues on the NYSE under ticker BFLY, is unaffected.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Butterfly Network, Inc. reported that it has announced preliminary financial results for the fourth quarter ended December 31, 2025. The company made this disclosure through a press release dated January 12, 2026, which is included as Exhibit 99.1 to this report. The Class A common stock trades on the New York Stock Exchange under the symbol BFLY, and its publicly traded warrants trade under BFLY WS. The report is signed on behalf of the company by Chief Financial Officer John Doherty.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.69%
Tags
current report
-
Rhea-AI Summary

Butterfly Network, Inc. executive vice president and chief financial officer John N. Doherty reported an automatic sale of company stock tied to tax withholding. On January 7, 2026, he sold 60,182 shares of Class A common stock at a weighted average price of $3.98 per share, with individual sale prices ranging from $3.915 to $4.055. According to the company’s “sell-to-cover” policy, these sales were made only to cover tax obligations arising from the vesting of restricted stock units and were not at his discretion. After the transaction, Doherty beneficially owned 1,234,688 shares of Butterfly Network Class A common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Butterfly Network, Inc. director and 10% owner Jonathan M. Rothberg reported sales of Class A common stock made indirectly through JAR TR, LLC. JAR TR, LLC sold 351,617 shares on 01/06/2026 at a weighted average price of $4.0294, 452,729 shares on 01/07/2026 at $4.1399, and 335,834 shares on 01/08/2026 at $4.1822, leaving no Class A shares held by that entity after the reported transactions.

The sales were effected under a Rule 10b5-1 trading plan adopted on March 5, 2025 for estate-planning purposes. Rothberg remains associated with substantial holdings of Class A and Class B common stock through direct ownership, his spouse, and multiple LLC and trust entities, while disclaiming beneficial ownership of those securities except to the extent of his pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

Butterfly Network Inc. insider Dr. Jonathan Rothberg has filed a notice to sell 335,834 shares of common stock through broker Jefferies on the NYSE, with an aggregate market value of 1,404,525.00. The filing reports that 226,200,000 shares of common stock are outstanding.

The shares to be sold were originally acquired in a private purchase from Butterfly Network Inc. on 08/31/2014, when 176,070 shares were bought for cash. The notice also lists multiple recent sales by Dr. Rothberg over the past three months, including 1,110,579 shares sold on 11/24/2025 for gross proceeds of 3,503,032.70 and 452,729 shares sold on 01/07/2026 for 1,874,252.00. By signing, the seller represents that he is not aware of undisclosed material adverse information about the company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

A holder of Butterfly Network Inc. common stock has filed a notice of intent to sell 452,729 shares through broker Jefferies on the NYSE, with an aggregate market value of $1,874,252.78. The filing states that 226,200,000 common shares are outstanding; this is a baseline figure, not the amount being sold. The seller acquired these 452,729 shares in a private purchase from Butterfly Network Inc. on 08/31/2014, paid in cash. The notice also lists multiple prior sales of Butterfly Network common stock over the past three months by the same seller, each with specified share amounts, dates, and gross proceeds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Butterfly Network Chief Technology Officer Victor Ku reported an automatic sale of company stock related to tax withholding. On January 5, 2026, he sold 35,968 shares of Butterfly Network Class A common stock at a weighted average price of $3.82 per share in a transaction coded as a sale.

According to the disclosure, Butterfly Network has a "sell-to-cover" policy for equity awards, and these shares were sold automatically to cover tax withholding triggered by the vesting of restricted stock units, rather than at Ku’s discretion. After this transaction, Ku beneficially owned 811,962 shares of Class A common stock directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Butterfly Network (BFLY)?

The current stock price of Butterfly Network (BFLY) is $3.04 as of February 15, 2026.

What is the market cap of Butterfly Network (BFLY)?

The market cap of Butterfly Network (BFLY) is approximately 767.9M.

BFLY Rankings

BFLY Stock Data

767.91M
36.93M
Medical Devices
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
BURLINGTON

BFLY RSS Feed